Prognostic features for response and survival in elderly patients with <emph type="3">de novo</emph> acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine

AP Grigg; J Reynolds; A McQuillan; SK Juneja; J Di Iulio; C Hui; C Smith; R Kimber; KF Bradstock; on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG)

doi:10.1080/10428190400013076

Prognostic features for response and survival in elderly patients with <emph type="3">de novo</emph> acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine

AP Grigg, J Reynolds, A McQuillan, SK Juneja, J Di Iulio, C Hui, C Smith, R Kimber, KF Bradstock, on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG)

Research output: Contribution to journal › Article › Research › peer-review

7 Citations (Scopus)

Original language	English
Pages (from-to)	367-375
Number of pages	9
Journal	Leukemia and Lymphoma
Volume	46
Issue number	3
DOIs	https://doi.org/10.1080/10428190400013076
Publication status	Published - 1 Jan 2005
Externally published	Yes

Access to Document

10.1080/10428190400013076

Cite this

Grigg, AP., Reynolds, J., McQuillan, A., Juneja, SK., Iulio, J. D., Hui, C., Smith, C., Kimber, R., Bradstock, KF., & on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG) (2005). Prognostic features for response and survival in elderly patients with <emph type="3">de novo</emph> acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine. Leukemia and Lymphoma, 46(3), 367-375. https://doi.org/10.1080/10428190400013076

@article{c80e08c2bb1644b8ac2ecdfe1bee0a0a,

title = "Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine",

author = "AP Grigg and J Reynolds and A McQuillan and SK Juneja and Iulio, {J Di} and C Hui and C Smith and R Kimber and KF Bradstock and {on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG)}",

note = "doi: 10.1080/10428190400013076",

year = "2005",

month = jan,

day = "1",

doi = "10.1080/10428190400013076",

language = "English",

volume = "46",

pages = "367--375",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor & Francis",

number = "3",

}

Grigg, AP, Reynolds, J, McQuillan, A, Juneja, SK, Iulio, JD, Hui, C, Smith, C, Kimber, R, Bradstock, KF & on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG) 2005, 'Prognostic features for response and survival in elderly patients with <emph type="3">de novo</emph> acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine', Leukemia and Lymphoma, vol. 46, no. 3, pp. 367-375. https://doi.org/10.1080/10428190400013076

Prognostic features for response and survival in elderly patients with <emph type="3">de novo</emph> acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine. / Grigg, AP; Reynolds, J; McQuillan, A et al.
In: Leukemia and Lymphoma, Vol. 46, No. 3, 01.01.2005, p. 367-375.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine

AU - Grigg, AP

AU - Reynolds, J

AU - McQuillan, A

AU - Juneja, SK

AU - Iulio, J Di

AU - Hui, C

AU - Smith, C

AU - Kimber, R

AU - Bradstock, KF

AU - on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG)

N1 - doi: 10.1080/10428190400013076

PY - 2005/1/1

Y1 - 2005/1/1

U2 - 10.1080/10428190400013076

DO - 10.1080/10428190400013076

M3 - Article

SN - 1042-8194

VL - 46

SP - 367

EP - 375

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 3

ER -